Xiafei Yu

653 total citations
23 papers, 311 citations indexed

About

Xiafei Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiafei Yu has authored 23 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Xiafei Yu's work include Ion Channels and Receptors (4 papers), RNA modifications and cancer (4 papers) and Plant Stress Responses and Tolerance (3 papers). Xiafei Yu is often cited by papers focused on Ion Channels and Receptors (4 papers), RNA modifications and cancer (4 papers) and Plant Stress Responses and Tolerance (3 papers). Xiafei Yu collaborates with scholars based in China, United Kingdom and Canada. Xiafei Yu's co-authors include Wei Yang, Xiaoan Liu, Xiaoqiang Zhang, Yanhui Zhu, Lin‐Hua Jiang, Fan Yang, Cheng Ma, Shuyun Yang, Hua Wang and Xiaoling Gu and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Chemical Engineering Journal.

In The Last Decade

Xiafei Yu

23 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiafei Yu China 11 131 63 63 61 45 23 311
Yi Luan China 9 172 1.3× 45 0.7× 58 0.9× 124 2.0× 68 1.5× 19 409
Yuan Hu China 10 267 2.0× 28 0.4× 103 1.6× 158 2.6× 71 1.6× 23 505
Irma Gresshoff Australia 7 179 1.4× 47 0.7× 35 0.6× 76 1.2× 65 1.4× 7 364
Guillaume Paul Grolez France 10 153 1.2× 19 0.3× 31 0.5× 176 2.9× 14 0.3× 16 332
Joseph Chapo United States 6 262 2.0× 23 0.4× 20 0.3× 143 2.3× 49 1.1× 7 398
Eujin Lee South Korea 11 191 1.5× 20 0.3× 52 0.8× 18 0.3× 27 0.6× 21 357
William R. Sones United Kingdom 9 383 2.9× 26 0.4× 57 0.9× 56 0.9× 31 0.7× 12 483
Daan Visser Netherlands 7 182 1.4× 103 1.6× 24 0.4× 137 2.2× 65 1.4× 7 452
Kati Kemppainen Finland 12 211 1.6× 9 0.1× 43 0.7× 88 1.4× 25 0.6× 16 330

Countries citing papers authored by Xiafei Yu

Since Specialization
Citations

This map shows the geographic impact of Xiafei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiafei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiafei Yu more than expected).

Fields of papers citing papers by Xiafei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiafei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiafei Yu. The network helps show where Xiafei Yu may publish in the future.

Co-authorship network of co-authors of Xiafei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiafei Yu. A scholar is included among the top collaborators of Xiafei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiafei Yu. Xiafei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Xiaoqiang, et al.. (2025). Melatonin-mediated cGAS-STING signal in senescent macrophages promote TNBC chemotherapy resistance and drive the SASP. Journal of Biological Chemistry. 301(5). 108438–108438. 4 indexed citations
3.
Gao, He, et al.. (2025). Piezoelectric-driven immunosuppressive remodeling: Ferroptosis/macrophage reprogramming for tumor therapy. Chemical Engineering Journal. 520. 165769–165769. 2 indexed citations
4.
Shi, Xiaoyue, Hao Ding, Yanhui Zhu, et al.. (2023). Comprehensive evaluation of cell death-related genes as novel diagnostic biomarkers for breast cancer. Heliyon. 9(11). e21341–e21341. 3 indexed citations
5.
Liu, Han‐Wei, Xiafei Yu, Zhen-Qi Liu, et al.. (2023). Bilirubin gates the TRPM2 channel as a direct agonist to exacerbate ischemic brain damage. Neuron. 111(10). 1609–1625.e6. 25 indexed citations
6.
Gu, M. H., Xiafei Yu, Xian Wu, et al.. (2023). LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer. Cancers. 15(10). 2773–2773. 1 indexed citations
7.
Zhang, Xiaoqiang, Xuyu Chen, Yanhui Zhu, et al.. (2023). Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer. Clinical and Translational Medicine. 13(9). e1398–e1398. 10 indexed citations
8.
Zhang, Hongfei, Xiafei Yu, Xiaoqiang Zhang, et al.. (2022). Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer. Frontiers in Immunology. 13. 933779–933779. 4 indexed citations
9.
Zhu, Yanhui, Yunfei Bai, Wanjun Gu, et al.. (2022). Radiogenomics analysis reveals the associations of dynamic contrast-enhanced–MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer. Frontiers in Oncology. 12. 943326–943326. 13 indexed citations
10.
Zhang, Xiaoqiang, Li Shen, Xiafei Yu, et al.. (2021). Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of N6-Methyladenosine-Related Long Noncoding RNA Regulators in Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 686675–686675. 17 indexed citations
11.
Yu, Xiafei, Yuan Xie, Xiaokang Zhang, et al.. (2021). Structural and functional basis of the selectivity filter as a gate in human TRPM2 channel. Cell Reports. 37(7). 110025–110025. 18 indexed citations
12.
Wu, Xian, Xiafei Yu, Yi Zhou, et al.. (2021). The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients. Cancer Management and Research. Volume 13. 1517–1527. 3 indexed citations
13.
Wang, Jiangqin, Xiafei Yu, Zhong Jie Ding, et al.. (2021). Structural basis of ALMT1-mediated aluminum resistance in Arabidopsis. Cell Research. 32(1). 89–98. 40 indexed citations
14.
Luo, Yuhuan, Xiafei Yu, Cheng Ma, Fan Yang, & Wei Yang. (2019). Effects of calcium-binding sites in the S2–S3 loop on human and Nematostella vectensis TRPM2 channel gating processes. Journal of Zhejiang University SCIENCE B. 20(12). 972–982. 6 indexed citations
15.
Yu, Peilin, Zhenming Liu, Xiafei Yu, et al.. (2019). Direct Gating of the TRPM2 Channel by cADPR via Specific Interactions with the ADPR Binding Pocket. Cell Reports. 27(12). 3684–3695.e4. 55 indexed citations
16.
Luo, Yuhuan, Xiafei Yu, Cheng Ma, Jianhong Luo, & Wei Yang. (2018). Identification of a Novel EF-Loop in the N-terminus of TRPM2 Channel Involved in Calcium Sensitivity. Frontiers in Pharmacology. 9. 581–581. 13 indexed citations
17.
Wang, Yingying, Xiaoling Gu, Chao Wang, et al.. (2016). The far-upstream element-binding protein 2 is correlated with proliferation and doxorubicin resistance in human breast cancer cell lines. Tumor Biology. 37(7). 9755–9769. 16 indexed citations
18.
Ji, Lili, Tingting Ni, Qun Xue, et al.. (2014). Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation. Journal of Molecular Histology. 45(5). 573–582. 19 indexed citations
19.
He, Song, Yuejiao Huang, Yuchan Wang, et al.. (2014). Histamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas. Leukemia & lymphoma. 56(7). 2153–2161. 4 indexed citations
20.
Yu, Xiafei, Qichao Ni, Jinpeng Chen, et al.. (2014). Knocking down the expression of adenylate cyclase-associated protein 1 inhibits the proliferation and migration of breast cancer cells. Experimental and Molecular Pathology. 96(2). 188–194. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026